Hydrocortisone for hormone replacement in large pituitary tumor surgery
Treatments studied
Part of Brain & nervous system, Cancer, Hormones & metabolism clinical trials.
This trial tests hydrocortisone as hormone replacement therapy after surgery for large pituitary tumors. It aims to help patients maintain healthy cortisol levels during recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old
- You have a pituitary tumor that is at least 2 centimeters wide
- You are scheduled for endoscopic transsphenoidal surgery (surgery through the nose)
- Your body’s natural stress hormone system (HPA axis) is working normally before surgery
- You do not have Cushing's disease or adrenal insufficiency
- You are not in an emergency or taking combined hormone therapy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of radiation therapy for pituitary tumors that are still making too much hormone after surgery. It aims to see if proton beam therapy can control hormones better than standard radiation with fewer side effects.
This study looks at whether blood and tissue markers, along with imaging features, can predict how aggressive a pituitary neuroendocrine tumor is and how it may affect long-term health. It aims to improve treatment decisions by better understanding these tumors.
This study compares two ways of giving steroid medicine after surgery to remove one adrenal gland. The goal is to find out which approach better protects patients from a condition where the body doesn't make enough steroid hormones.
This trial tests whether hydrocortisone (a cortisol replacement) helps people who feel symptoms of adrenal insufficiency after they stop long-term prednisolone. It compares hydrocortisone versus placebo to see if symptoms improve and dosing is safer/effective.
This trial compares two steroid medicines (hydrocortisone and methylprednisolone) to see which one works better for people whose adrenal glands have stopped working properly after taking high doses of steroids for a long time. It aims to find the safest and most effective way to replace the missing hormones.
This trial studies whether a once-daily hydrocortisone tablet works as well as standard steroid treatment for adults with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency. It aims to improve how safely and conveniently hormone replacement is taken each day.
Hear when a new Pituitary Adenoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.